Related Experiment Video
Updated: Jun 20, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha
Takaya Tsuno1, Josef Mejido, Tongmao Zhao
1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
A number of tumors are still resistant to the antiproliferative activity of human interferon (IFN)-alpha. The Janus kinases/Signal Transducers and Activators of Transcription (JAK-STAT) pathway plays an important role in initial IFN signaling. To enhance the antiproliferative activity of IFN-alpha, it is important to elucidate which factors in the JAK-STAT pathway play a key role in eliciting this activity. In human ovarian adenocarcinoma OVCAR3 cells sensitive to both IFN-alpha and IFN-gamma, only IFN regulatory factor 9 (IRF9)-RNA interference (RNAi) completely inhibited the antiproliferative activity of IFN-alpha among the intracellular JAK-STAT pathway factors. Conversely, Stat1-RNAi did not inhibit the antiproliferative activity of IFN-alpha, whereas it partially inhibited that of IFN-gamma. As a cell death pathway, it is reported that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through TRAIL-receptor (R) 1 and TRAIL-R2. In IFN-alpha-treated OVCAR3 cells, IRF9-RNAi inhibited transcription of TRAIL whereas Stat1-RNAi did not, suggesting that the transcription of TRAIL induced by IFN-alpha predominantly required IRF9. Furthermore, IFN-stimulated response element-like motifs of TRAIL bound to IFN-stimulated gene factor 3 (ISGF3) complex after IFN-alpha treatment. Subsequently, TRAIL-R2-RNAi inhibited both antiproliferative activities of IFN-alpha and TRAIL, suggesting that TRAIL-R2 mediated both IFN-alpha and TRAIL signals to elicit their antiproliferative activities. Finally, IRF9 overexpression facilitated IFN-alpha-induced apoptosis in T98G (human glioblastoma multiforme) cells, which were resistant to IFN-alpha. Thus, this study suggests that IRF9 is the key factor for eliciting the antiproliferative activity of IFN-alpha and TRAIL may be one of the potential mediators.
Insights
Interferon-alpha (IFN-alpha) resistance in tumors can be overcome by targeting Interferon Regulatory Factor 9 (IRF9). IRF9 is key for IFN-alpha
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Human interferon-alpha (IFN-alpha) exhibits limited antiproliferative effects on certain tumors.
- The Janus kinases/Signal Transducers and Activators of Transcription (JAK-STAT) pathway is crucial for initial IFN signaling.
- Identifying key JAK-STAT pathway factors is essential to enhance IFN-alpha's antiproliferative activity.
Purpose of the Study:
- To elucidate the specific roles of JAK-STAT pathway factors in mediating IFN-alpha's antiproliferative activity.
- To investigate the involvement of Interferon Regulatory Factor 9 (IRF9) and STAT1 in IFN-alpha signaling.
- To explore the relationship between IRF9, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and IFN-alpha-induced apoptosis.
Main Methods:
- Utilized RNA interference (RNAi) to inhibit specific genes (IRF9, STAT1, TRAIL-R2) in human ovarian adenocarcinoma (OVCAR3) and glioblastoma (T98G) cells.
- Assessed the antiproliferative effects of IFN-alpha and IFN-gamma following gene silencing.
- Analyzed the transcriptional regulation of TRAIL and its interaction with the IFN-stimulated gene factor 3 (ISGF3) complex.
- Investigated the role of TRAIL-receptor 2 (TRAIL-R2) in mediating IFN-alpha and TRAIL signaling.
Main Results:
- IRF9-RNAi completely abolished IFN-alpha's antiproliferative activity in OVCAR3 cells, while STAT1-RNAi had no effect.
- IRF9-RNAi inhibited IFN-alpha-induced TRAIL transcription, suggesting IRF9's critical role in TRAIL induction.
- IFN-alpha treatment led to the binding of the ISGF3 complex to TRAIL motifs.
- TRAIL-R2-RNAi impaired the antiproliferative effects of both IFN-alpha and TRAIL.
- IRF9 overexpression enhanced IFN-alpha-induced apoptosis in IFN-alpha-resistant T98G cells.
Conclusions:
- IRF9 is identified as the key intracellular factor responsible for mediating the antiproliferative activity of IFN-alpha.
- TRAIL acts as a potential mediator of IFN-alpha's antiproliferative effects, with IRF9 regulating its transcription.
- TRAIL-R2 is implicated as a crucial receptor in transmitting both IFN-alpha and TRAIL signals for antiproliferative outcomes.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

